P3 Health Partners Inc.

For the period ended Mar 31, 2026. Filed May 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 14, 2026

PIII$3.38-20.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

	Three Months Ended March 31,
	2026	2025
OPERATING REVENUE:
Capitated revenue	$379,499	$369,517
Other revenue	6,891	3,708
TOTAL OPERATING REVENUE	386,390	373,225
OPERATING EXPENSE:
Medical expense	336,024	372,043
Premium deficiency reserve	(4,715)	(6,962)
Corporate, general and administrative expense	25,543	24,999
Sales and marketing expense	227	181
Depreciation and amortization	21,074	21,052
TOTAL OPERATING EXPENSE	378,153	411,313
OPERATING INCOME (LOSS)	8,237	(38,088)
OTHER INCOME (EXPENSE):
Interest expense	(16,766)	(8,725)
Mark-to-market of stock warrants	330	3,322
Other	242	318
TOTAL OTHER EXPENSE	(16,194)	(5,085)
LOSS BEFORE INCOME TAXES	(7,957)	(43,173)
INCOME TAX BENEFIT (PROVISION)	10,997	(1,073)
NET INCOME (LOSS)	3,040	(44,246)
LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NON-CONTROLLING INTERESTS	1,817	(23,766)
NET INCOME (LOSS) ATTRIBUTABLE TO CONTROLLING INTEREST	$1,223	$(20,480)
NET INCOME (LOSS) PER SHARE (Note 8):
Basic	$0.37	$(6.28)
Diluted	$0.32	$(6.28)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (Note 8):
Basic	3,288	3,260
Diluted	8,417	3,260

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.